Stilla Technologies completes €16 Million Series A
Novel digital PCR system
23-Nov-2018 -
Stilla Technologies, provider of pioneering digital PCR solutions for high precision genetic analysis, announced today the successful completion of a Series A financing round of 16 million euros ($18 Million) led by Illumina Ventures, with participation from Kurma Partners, LBO France, BNP ...
cancer diagnostics
digital PCR
DNA mutation
+3